J&J unites with patient groups on lung cancer care decisions

J&J unites with patient groups on lung cancer care decisions

The collaboration aims to strengthen shared decision-making processes between patients and clinicians across the Asia Pacific region.
Johnson & Johnson and Ho Chi Minh City Oncology Hospital to unlock cancer treatment access

Johnson & Johnson and Ho Chi Minh City Oncology Hospital to unlock cancer treatment access

Johnson & Johnson Vietnam inked a MoU with Ho Chi Minh City Oncology Hospital on September 9.
Wealthy gain as world demands fair access

Wealthy gain as world demands fair access

While some of the world’s largest vaccine makers have committed to increase COVID-19 vaccine access to middle and low-income countries, there remains uncertainty over patent waivers.
Pharmaceutical giants shell out billions to shareholders amid vaccine apartheid

Pharmaceutical giants shell out billions to shareholders amid vaccine apartheid

Pfizer, Johnson & Johnson, and AstraZeneca have paid enough in dividends and stock buybacks to shareholders to inoculate the population of Africa.
EU to get 50 million Pfizer doses early as US prolongs J&J pause

EU to get 50 million Pfizer doses early as US prolongs J&J pause

The European Union said Wednesday that it is expecting 50 million Pfizer coronavirus vaccine doses earlier than expected, as the United States said it would continue a pause in vaccinations using the Johnson & Johnson shot for at least another week so regulators can assess possible blood clot links.
Johnson & Johnson to delay European Covid-19 vaccine rollout

Johnson & Johnson to delay European Covid-19 vaccine rollout

Johnson & Johnson said Tuesday it will delay rollout of its Covid-19 vaccine in Europe after US authorities moved to suspend use of the shot due to health concerns.
AstraZeneca, Johnson & Johnson COVID-19 vaccine trials back on track in US

AstraZeneca, Johnson & Johnson COVID-19 vaccine trials back on track in US

WASHINGTON: Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States on Friday (Oct 23), providing a glimmer of hope as the number of cases skyrockets across the country.
Johnson & Johnson moves to buoy investors over paused Covid vaccine trial

Johnson & Johnson moves to buoy investors over paused Covid vaccine trial

US pharmaceutical giant Johnson & Johnson sought Tuesday to reassure investors after its stock slumped on an announcement that it was pausing a Covid-19 vaccine trial over a sick participant.
J&J implored to verify powder safety

J&J implored to verify powder safety

International healthcare supplier Johnson & Johnson, despite facing thousands of lawsuits in the United States and Canada as its talcum powder has been allegedly harming women for years, has continued to sell the signature product in other countries across the globe, including Vietnam.
Brazil approves final tests of J&J virus vaccine

Brazil approves final tests of J&J virus vaccine

Brazilian health regulators said Tuesday they had approved Johnson & Johnson's experimental vaccine against the new coronavirus for the final stage of clinical trials, the fourth vaccine to receive widespread testing in the hard-hit country.
US signs $1 billion vaccine deal with Johnson & Johnson

US signs $1 billion vaccine deal with Johnson & Johnson

The US government Wednesday announced a new $1 billion investment in a COVID-19 vaccine being developed by Johnson & Johnson, guaranteeing 100 million doses.
Pharma groups to profit from virus?

Pharma groups to profit from virus?

The top 10 global pharmaceutical companies are being scrutinised and advised not to prevent or delay a vaccine for COVID-19 from reaching vulnerable people to gain profits, triggering global concerns over their social responsibility.
Johnson & Johnson ordered to pay US$344 million over pelvic mesh claims

Johnson & Johnson ordered to pay US$344 million over pelvic mesh claims

A US judge on Thursday (Jan 30) ordered Johnson & Johnson to pay US$344 million for false and deceptive marketing of pelvic mesh products used by tens of thousands of women in California.
Improving the quality of medical examination and hospital treatment

Improving the quality of medical examination and hospital treatment

The MoH and the Centre of Developing Medical Management Capacity organised a training course for 60 hospital quality assessment auditors in southern Vietnam.
J&J ordered to pay US$4.7 billion in Missouri asbestos cancer case

J&J ordered to pay US$4.7 billion in Missouri asbestos cancer case

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record US$4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer.
1 2